Recombinant GALT antibody

Catalog No. ABIN7880846

This Rabbit Monoclonal antibody specifically detects GALT in WB, IF and ICC. It exhibits reactivity toward Human, Rat and Mouse.

Quick Overview for Recombinant GALT antibody (ABIN7880846)

Target: GALT (Galactose-1-Phosphate Uridylyltransferase (GALT))

Antibody Type: Recombinant Antibody

Reactivity: Human, Rat, Mouse

Host: Rabbit

Clonality: Monoclonal

Conjugate: This GALT antibody is un-conjugated

Application: Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC)

Clone: 29G81

Product Details anti-GALT Antibody

Purpose: GALT Antibody / Galactose-1-phosphate uridylyltransferase

Purification: Affinity chromatography

Immunogen: A synthesized peptide derived from human GALT was used as the immunogen for the GALT antibody.

Isotype: IgG

Application Details

Application Notes: Optimal dilution of the GALT antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store the GALT antibody at -20oC.

Target Details for GALT

Target: GALT (Galactose-1-Phosphate Uridylyltransferase (GALT))

Alternative Name: GALT

Background: GALT antibody detects Galactose-1-phosphate uridylyltransferase, encoded by the GALT gene. This enzyme plays an essential role in the Leloir pathway of galactose metabolism, where it catalyzes the transfer of uridylyl groups between UDP glucose and galactose-1-phosphate to form UDP galactose and glucose-1-phosphate. This reaction is central to the proper metabolism of dietary galactose, and deficiency in GALT activity leads to classic galactosemia, an inherited metabolic disorder. GALT antibody allows researchers to study enzyme expression, localization, and regulation in both normal physiology and disease contexts.

Galactose-1-phosphate uridylyltransferase is widely expressed in liver, kidney, and other metabolically active tissues. Research using GALT antibody has revealed that enzyme activity is tightly regulated, as accumulation of galactose-1-phosphate is toxic to cells. In classic galactosemia, mutations in the GALT gene result in absent or reduced activity, causing life threatening complications in infants such as liver failure, sepsis, and developmental delays. Early detection and dietary management are crucial, but long term complications still occur, making GALT antibody valuable in research aimed at improving therapies and understanding pathophysiology.

Beyond metabolic disorders, GALT has been studied in cancer and broader metabolic regulation. Alterations in carbohydrate metabolism are a hallmark of tumor cells, and studies using GALT antibody have suggested that reduced GALT activity may influence cancer cell growth through altered glycosylation and signaling pathways. In addition, polymorphisms in the GALT gene have been examined in population studies for their potential links to reproductive outcomes and susceptibility to metabolic stress. These investigations underscore the enzyme's relevance beyond rare genetic disease.

GALT antibody is widely used in western blotting, immunohistochemistry, and enzymatic activity assays. Western blotting confirms protein levels in cell and tissue lysates, while immunohistochemistry highlights tissue specific distribution. Functional assays combined with GALT antibody detection assess enzymatic activity under different experimental conditions, providing a comprehensive view of GALT regulation. These approaches make GALT antibody a powerful tool for metabolic research, clinical investigation, and biomarker development.

By supplying validated GALT antibody reagents, NSJ Bioreagents supports research into carbohydrate metabolism, genetic disease, and cancer biology. Detecting Galactose-1-phosphate uridylyltransferase provides insight into one of the most fundamental metabolic pathways and its connections to human health and disease.

UniProt: P07902